Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials.

Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials. J Clin Oncol. 2023 03 01; 41(7):1376-1382.

View in: PubMed

subject areas

Adjuvants, Immunologic
Adult
Antineoplastic Agents, Hormonal
Breast Neoplasms
Chemotherapy, Adjuvant
Disease-Free Survival
Female
Follow-Up Studies
Humans
Premenopause
Tamoxifen

authors with profiles

Gini Fleming